At molecular level, although conflicting data are reported in literature regarding PGRMC1-initiated effects in breast cancer cells [165], PGRMC1 activation enhances PI3K/Akt/mTOR and EGFR-mediated signaling pathways, resulting in the increased proliferation [166] and alteration of lipid metabolism [167] in ER+ and triple-negative breast tumors. Here, EGFR is linked to breast cancer.